Janssen Steps Away from Phase I Prostate Cancer Study, Cites Patient Enrollment Issues

Janssen Steps Away from Phase I Prostate Cancer Study, Cites Patient Enrollment Issues

Source: 
BioSpace
snippet: 

ESSA Pharma Inc. confirmed in a Monday morning announcement that Janssen has stepped away from a prostate cancer collaboration due to “operational recruitment challenges."